Lexology October 18, 2023
Hall Benefits Law

A recent Tenth Circuit decision invalidating portions of an Oklahoma law regulating pharmacy benefit managers (PBMs) based on preemption could negatively affect similar laws in other states. The appellate court found that the Employee Retirement Income Security Administration (ERISA) and Medicare Part D preempted the challenged provisions of the PBM law. In its decision, the Tenth Circuit also explicitly acknowledged that the U.S. Supreme Court ruling in Rutledge v. PCMA, in which the high Court found that ERISA did not preempt an Arkansas PBM law, did not alter its preemption analysis.

Some see the Tenth Circuit decision as a big victory for PBMs, who currently face scrutiny by state and federal governments. The decision is also good for employers seeking...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Govt Agencies, Pharma, Pharma / Biotech, Regulations, States
Eli Lilly to invest $27B in manufacturing
Eli Lilly plans at least $27 billion in new U.S. manufacturing investments
How AI Drug Manufacturing Is Changing the Game
Radiopharmaceutical Manufacturing: A High-Stakes Race Against Time
Will Pharma Continue Efforts to Diversify Clinical Trials?

Share This Article